I-Methyl 4-(Bromomethyl)-3-Methoxybenzoate CAS 70264-94-7 Zafirlukast Intermediate

Incazelo emfushane:

Igama: Methyl 4-(Bromomethyl)-3-Methoxybenzoate

I-CAS: 70264-94-7

I-Assay (HPLC): ≥98.0%

Ukubukeka: Impushana Ephuzi Ephaphathekile

I-Intermediate of Zafirlukast (CAS 107753-78-6) I-Antiasthmatic

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Ukunikezwa Komkhiqizi, Ukuhlanzeka Okuphezulu, Ukukhiqizwa Kwezohwebo
Igama Lekhemikhali: Methyl 4-(Bromomethyl)-3-Methoxybenzoate
I-CAS: 70264-94-7

Chemical Properties:

Igama Lekhemikhali I-Methyl 4-(Bromomethyl)-3-Methoxybenzoate
Omqondofana 4-(Bromomethyl) -3-methoxybenzoic Acid Methyl Ester;I-Methyl 4-(Bromomethyl)-m-anisate;4-(Bromomethyl)-m-anisic Acid Methyl Ester
Inombolo ye-CAS 70264-94-7
Inombolo yeCAT I-RF-PI437
Isimo Sesitoko Kukhona kusitoki
I-Molecular Formula I-C10H11BrO3
Isisindo samangqamuzana 259.10
I-Melting Point 92.0 ukuze 94.0℃
Ukuminyana 1.432
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Ephuzi Ephaphathekile
Indlela Yokuhlola / Yokuhlaziya ≥98.0% (HPLC)
Ukulahlekelwa Ekumisweni ≤1.0%
Izinsalela ekushiseni ≤0.50%
Ukungcola Okuphelele ≤2.0%
Izinsimbi Ezisindayo ≤20ppm
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate of Zafirlukast (CAS: 107753-78-6), Isetshenziswa njenge-antiasthmatic

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Methyl 4-(Bromomethyl)-3-Methoxybenzoate (CAS 70264-94-7) isetshenziswa njengendawo ephakathi ye-Zafirlukast (CAS: 107753-78-6).I-Zafirlukast iyimbangi ye-lys-LTs yomlomo ekhetha kakhulu futhi ethatha isikhathi eside.I-leukotrienes idlala indima ebalulekile ku-pathogenesis ye-asthma.Lezi zinto zingama-peptide, ezikwazi ukubopha ngokukhetha ku-LTC4, LTD4 kanye ne-LTE4 receptor ngokuphikisana nomphumela wayo, ukwehlisa izimpawu zesifuba somoya kanye nokwenza ngcono ukusebenza kwamaphaphu.Lo mkhiqizo womabili uyisisetshenziswa esivimbela ukuvuvukala okubangelwa isifuba somoya (iphikisana nomsebenzi we-leukotriene proinflammatory) kanye nomuthi wokusiza wesifuba somoya (i-bronchial asthma) (ungaphikisani nokufinyezwa kwemisipha ebushelelezi ye-leukotriene).Ukusetshenziswa kwalo mkhiqizo akuguquli ukusabela kwemisipha ebushelelezi kuma-β2 receptors futhi kusebenza kahle ekwelapheni i-bronchoconstriction ebangelwa i-antigen, i-aspirin, ukuvivinya umzimba nomoya obandayo, ukwazi ukunciphisa umthamo we-hormone kanye ne-β2 receptor agonist.

Bhala umyalezo wakho lapha futhi usithumelele wona